Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.

Peter Freedman wants to “have his cake and eat it”, with the Freedman Group’s latest US acquisition upping its audio recording industry market share and hopefully paving the way to an ASX listing.

Cathy O'Sullivan, editorial director for CIO in Australia and New Zealand, sat with Southern Cross Travel Insurance CTO Alex Smart to discuss how a great team culture and healthy conflict leads to ...

Seven candidates are running for four four-year terms on the Southern Lehigh School Board. Here are their answers to The ...

The so-called 'smart hubs' also have a built-in defibrillator and a “nasal Naloxone opioid antagonist” – a drug used for the ...

Talks aimed at settling a strike between train engineers and New Jersey’s huge commuter railroad will pick up on Saturday and ...

IREDA has initiated proceedings under Section 7 of the Insolvency and Bankruptcy Code against Gensol Engineering Limited over ...

Operator: Good afternoon, everyone, and welcome to the Bridgeline Digital Second Quarter 2025 Earnings Call. [Operator ...

The project, launched by the WeLoveU Foundation in partnership with East Hartford, is designed to support local pollinators ...

Roku ( ROKU 12.97%) reported its 2025 first-quarter financial results not long ago. Revenue of just over $1 billion and the ...

Banks, non-banking financial companies, investment platforms, climate financing institutions and even individuals are booking ...